1. Creatinine level is less than 1.10. <br/ >2. History of severe liver or kidney diseases. <br/ >3. History of any malignancies. <br/ >4. Subjects who are hypersensitive to herbal medications. <br/ >5. Subjects who are participating in any other trial within 30 days prior to consent. <br/ >6. Pregnant or lactating women. <br/ >7. Any other circumstances that the investigator considers inappropriate for the participation in this study. <br/ >8. Subjects who are unwilling to follow the study plan. <br/ >9. Any condition which subject may have which can cause increase risk of bleeding.

1. Creatinine level is less than 1.10. <br/ >2. History of severe liver or kidney diseases. <br/ >3. History of any malignancies. <br/ >4. Subjects who are hypersensitive to herbal medications. <br/ >5. Subjects who are participating in any other trial within 30 days prior to consent. <br/ >6. Pregnant or lactating women. <br/ >7. Any other circumstances that the investigator considers inappropriate for the participation in this study. <br/ >8. Subjects who are unwilling to follow the study plan. <br/ >9. Any condition which subject may have which can cause increase risk of bleeding.

N/A

N/A

1. Creatinine level is less than 1.10. <br/ >2. History of severe liver or kidney diseases. <br/ >3. History of any malignancies. <br/ >4. Subjects who are hypersensitive to herbal medications. <br/ >5. Subjects who are participating in any other trial within 30 days prior to consent. <br/ >6. Pregnant or lactating women. <br/ >7. Any other circumstances that the investigator considers inappropriate for the participation in this study. <br/ >8. Subjects who are unwilling to follow the study plan. <br/ >9. Any condition which subject may have which can cause increase risk of bleeding.

1. Creatinine level is less than 1.10. <br/ >2. History of severe liver or kidney diseases. <br/ >3. History of any malignancies. <br/ >4. Subjects who are hypersensitive to herbal medications. <br/ >5. Subjects who are participating in any other trial within 30 days prior to consent. <br/ >6. Pregnant or lactating women. <br/ >7. Any other circumstances that the investigator considers inappropriate for the participation in this study. <br/ >8. Subjects who are unwilling to follow the study plan. <br/ >9. Any condition which subject may have which can cause increase risk of bleeding.